Answer
Ocular icterus, nausea and jaundice are classified as very common (≥1 in 10) with cobicistat-boosted atazanavir, based on 144 weeks of trial experience with accompanying emtricitabine and tenofovir disoproxil fumarate.
Sources for this answer
- Tybost 150mg film coated tabletGilead Sciences Ltd · emc · SmPC §4.8 Undesirable effects · Version 18Document updated
Sources checked